Proteon Therapeutics (PRTO) Short Interest Ratio & Short Volume → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free PRTO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Proteon Therapeutics Short Interest DataCurrent Short Volume7,300 sharesPrevious Short Volume6,700 sharesChange Vs. Previous Month+8.96%Dollar Volume Sold Short$247,032.00Short Interest Ratio / Days to Cover0.6Last Record DateJanuary 31, 2020Outstanding Shares22,179,000 sharesFloat Size222,600 sharesShort Percent of Float3.28%Today's Trading Volume83,563 sharesAverage Trading Volume1,113,217 sharesToday's Volume Vs. Average8% Short Selling Proteon Therapeutics ? Sign up to receive the latest short interest report for Proteon Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPRTO Short Interest Over TimePRTO Days to Cover Over TimePRTO Percentage of Float Shorted Over Time Ad MarketBeatYour $200 account credit is about to expireUpdate to MarketBeat All Access and Save $300 on Your Annual SubscriptionStart Your Risk-Free Trial Here Proteon Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20207,300 shares $247,032.00 +9.0%3.3%0.6 $33.84 1/15/20206,700 shares $180,900.00 -88.6%N/A0.8 $27.00 12/31/201958,500 shares $23,985.00 -52.6%20.1%7.9 $0.41 PRTO Short Interest - Frequently Asked Questions What is Proteon Therapeutics' current short interest? Short interest is the volume of Proteon Therapeutics shares that have been sold short but have not yet been covered or closed out. As of January 31st, investors have sold 7,300 shares of PRTO short. 3.28% of Proteon Therapeutics' shares are currently sold short. Learn More on Proteon Therapeutics' current short interest. What is a good short interest ratio for Proteon Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PRTO shares currently have a short interest ratio of 1.0. Learn More on Proteon Therapeutics's short interest ratio. What is a good short interest percentage for Proteon Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.28% of Proteon Therapeutics' floating shares are currently sold short. Is Proteon Therapeutics' short interest increasing or decreasing? Proteon Therapeutics saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 7,300 shares, an increase of 9.0% from the previous total of 6,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Proteon Therapeutics' float size? Proteon Therapeutics currently has issued a total of 22,179,000 shares. Some of Proteon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Proteon Therapeutics currently has a public float of 222,600 shares. How does Proteon Therapeutics' short interest compare to its competitors? 3.28% of Proteon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Proteon Therapeutics: AlloVir, Inc. (5.46%), Zura Bio Limited (1.75%), Elutia Inc. (0.10%), Athira Pharma, Inc. (2.77%), Aligos Therapeutics, Inc. (0.48%), Vigil Neuroscience, Inc. (7.64%), Instil Bio, Inc. (0.38%), Cognition Therapeutics, Inc. (1.03%), Semper Paratus Acquisition Co. (0.25%), Passage Bio, Inc. (3.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($17.72 billion), Netflix, Inc. ($7.24 billion), Charter Communications, Inc. ($4.67 billion), Microchip Technology Incorporated ($3.34 billion), The Charles Schwab Co. ($2.53 billion), Match Group, Inc. ($2.07 billion), Carvana Co. ($1.86 billion), Omnicom Group Inc. ($1.86 billion), Snap Inc. ($1.75 billion), and Zillow Group, Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Proteon Therapeutics stock? Short selling PRTO is an investing strategy that aims to generate trading profit from Proteon Therapeutics as its price is falling. PRTO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Proteon Therapeutics? A short squeeze for Proteon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTO, which in turn drives the price of the stock up even further. How often is Proteon Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTO, twice per month. The most recent reporting period available is January, 31 2020. More Short Interest Resources from MarketBeat Related Companies: ALVR Short Squeeze ZURA Short Squeeze ELUT Short Squeeze ATHA Short Squeeze ALGS Short Squeeze VIGL Short Squeeze TIL Short Squeeze CGTX Short Squeeze LGST Short Squeeze PASG Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTO) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryOnly a fool would buy Nvidia today… Porter & CompanyMost important medical advance in 100 yearsThe Oxford Club